Single Dose Of Vaccine Enough For Covid Recovered Patients, Claim BHU Researchers

This as researchers at the Banaras Hindu University (BHU) claim the single dose of vaccine is enough for the patients, who have recovered from Covid-19.

Representative Image

Varanasi: With several states running out of Covid-19 vaccines and the people expressing concern about missing their scheduled second dose, researchers at the Banaras Hindu University (BHU) claim the single dose of vaccine is enough for the patients, who have recovered from Covid-19.

Elaborting about the claim, Gyaneshwer Chaubey, Professor, Department of Zoology, BHU, said that they studied the “effect of the vaccine on Covid recovered and non-infected people” to derive this conclusion.

READ: 'Change Policies': SC Grills Centre On Vaccination Drive, Dual Pricing & Inaccessibility In Rural India

“Antibodies in the recovered people developed in the first week,” ANI quoted Chaubey as saying.

Reportedly, a letter has been sent to PM Narendra Modi in this regard.

Meanwhile, the Union Health Ministry as part of its commitment to pro-actively guide, review and monitor the Covid-19 vaccination drive held a review meeting through video conferencing with the administrators from the states and Union Territories on the progress of vaccination.

This comes in the backdrop of more flexibilities given to the states to enhance the pace of vaccination and increased vaccine supplies for June 2021 shared with the states and UTs through the advance vaccine visibility calendar.

Union Health Secretary Rajesh Bhushan, who chaired the meeting, appreciated the collective efforts of the states and UTs to increase the pace of vaccination in last week of May as most of the vaccine supply of the current month reached the states towards the end.

He also pointed out there is a substantial scope to accelerate the pace of vaccination even further.

The Health Secretary also assured that the Centre will provide the states and UTs with the available buffer stock to urgently replenish their depleting stocks so that the vaccination drive carries on with a steady pace.